Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gadebusch

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Biochemical Society Transactions|April 1, 1986
Pre-clinical microbiology and pharmacology of norfloxacinH H Gadebusch
Infection and Immunity|July 1, 1971
Epicillin: in vitro laboratory studiesH Basch, R Erickson, H Gadebusch
International Journal of Antimicrobial Agents|January 1, 1991
Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisitedH H Gadebusch, D L Shungu
Antimicrobial Agents and Chemotherapy|September 1, 1974
New antimicrobial nitrofuran, trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-delta2-1,2,4-oxadiazole: antibacterial, antifungal, and antiprotozoal activities in vitroH H Gadebusch, H I Basch
The Journal of Antimicrobial Chemotherapy|October 1, 1983
Antagonism between cefoxitin and other beta-lactams: a new perspectiveR A Fromtling, H H Gadebusch
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Ethanol-cephalosporin antibiotic interactions: an animal model for the detection of disulfiram (Antabuse)-like effectsR A Fromtling, H H Gadebusch
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Antimicrobial activities of alpha, omega-bis-(2,2'-dipyridylamino)-alkane bisquaternary saltsH H GADEBUSCH, C J CAVALLITO
Antimicrobial Agents and Chemotherapy|February 1, 1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)D L Shungu, E Weinberg, H H Gadebusch
Journal of Clinical Microbiology|February 1, 1984
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agentsE Weinberg, D L Shungu, H H Gadebusch
Antimicrobial Agents and Chemotherapy|January 1, 1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogensD L Shungu, E Weinberg, H H Gadebusch
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Biochemical Society Transactions|April 1, 1986
Pre-clinical microbiology and pharmacology of norfloxacinH H Gadebusch
Infection and Immunity|July 1, 1971
Epicillin: in vitro laboratory studiesH Basch, R Erickson, H Gadebusch
International Journal of Antimicrobial Agents|January 1, 1991
Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisitedH H Gadebusch, D L Shungu
Antimicrobial Agents and Chemotherapy|September 1, 1974
New antimicrobial nitrofuran, trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-delta2-1,2,4-oxadiazole: antibacterial, antifungal, and antiprotozoal activities in vitroH H Gadebusch, H I Basch
The Journal of Antimicrobial Chemotherapy|October 1, 1983
Antagonism between cefoxitin and other beta-lactams: a new perspectiveR A Fromtling, H H Gadebusch
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1983
Ethanol-cephalosporin antibiotic interactions: an animal model for the detection of disulfiram (Antabuse)-like effectsR A Fromtling, H H Gadebusch
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
Antimicrobial activities of alpha, omega-bis-(2,2'-dipyridylamino)-alkane bisquaternary saltsH H GADEBUSCH, C J CAVALLITO
Antimicrobial Agents and Chemotherapy|February 1, 1983
Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)D L Shungu, E Weinberg, H H Gadebusch
Journal of Clinical Microbiology|February 1, 1984
Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agentsE Weinberg, D L Shungu, H H Gadebusch
Antimicrobial Agents and Chemotherapy|January 1, 1983
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogensD L Shungu, E Weinberg, H H Gadebusch
Pageof 5